{"id":15122,"date":"2025-11-06T10:51:30","date_gmt":"2025-11-06T10:51:30","guid":{"rendered":"https:\/\/infundpros.com\/?p=15122"},"modified":"2025-11-06T10:51:30","modified_gmt":"2025-11-06T10:51:30","slug":"cytokinetics-incorporated-cytk-q3-2025-earnings-call-transcript","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=15122","title":{"rendered":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript"},"content":{"rendered":"<div>\n<p class=\"transcript-company-participants-title\"><strong>Company Participants<\/strong><\/p>\n<p><span>Diane Weiser &#8211; Senior Vice President of Corporate Affairs<\/span><br \/><span>Robert I. Blum &#8211; CEO, President &amp; Director<\/span><br \/><span>Andrew Callos &#8211; Executive VP &amp; Chief Commercial Officer<\/span><br \/><span>Fady Malik &#8211; Executive Vice President of Research &amp; Development<\/span><br \/><span>Stuart Kupfer &#8211; Senior VP &amp; Chief Medical Officer<\/span><br \/><span>Sung Lee &#8211; EVP &amp; CFO<\/span><\/p>\n<\/p><\/div>\n<div>\n<p class=\"transcript-other-participants-title\"><strong>Conference Call Participants<\/strong><\/p>\n<p><span>Huidong Wang<\/span><br \/><span>Salim Syed<\/span><br \/><span>Zaki Molvi &#8211; Jefferies LLC, Research Division<\/span><br \/><span>Carter Gould &#8211; Cantor Fitzgerald &amp; Co., Research Division<\/span><br \/><span>James Condulis &#8211; Stifel, Nicolaus &amp; Company, Incorporated, Research Division<\/span><br \/><span>Cory Kasimov &#8211; Evercore ISI Institutional Equities, Research Division<\/span><br \/><span>Caroline Poacher<\/span><br \/><span>Maxwell Skor &#8211; Morgan Stanley, Research Division<\/span><br \/><span>Yasmeen Rahimi &#8211; Piper Sandler &amp; Co., Research Division<\/span><br \/><span>Roanna Clarissa Ruiz &#8211; Leerink Partners LLC, Research Division<\/span><br \/><span>Mayank Mamtani &#8211; B. Riley Securities, Inc., Research Division<\/span><br \/><span>Joseph Pantginis &#8211; H.C. Wainwright &amp; Co, LLC, Research Division<\/span><br \/><span>Kyuwon Choi &#8211; Goldman Sachs Group, Inc., Research Division<\/span><br \/><span>John Gionco &#8211; Needham &amp; Company, LLC, Research Division<\/span><br \/><span>Jason Zemansky &#8211; BofA Securities, Research Division<\/span><\/p>\n<\/p><\/div>\n<div>\n<p class=\"transcript-presentation-title\"><strong>Presentation<\/strong><\/p>\n<div class=\"transcript-presentation-section\" seq=\"0\">\n<p class=\"transcript-presentation-section-title\"><span><strong>Operator<\/strong><\/span><\/p>\n<p>Thank you for standing by, and welcome to the Cytokinetics Q3 2025 Earnings Conference Call. This call is being recorded and all participants will be in a listen-only mode. [Operator Instructions]<\/p>\n<p>I would now like to turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Affairs. Please go ahead.<\/p>\n<\/p><\/div>\n<div class=\"transcript-presentation-section\" seq=\"1\">\n<p class=\"transcript-presentation-section-title\"><span><strong>Diane Weiser<\/strong><\/span><br \/><span><i>Senior Vice President of Corporate Affairs<\/i><\/span><\/p>\n<p>Good afternoon, and thanks for joining us on the call today. Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments. Andrew Callos, EVP and Chief Commercial Officer, will address commercial readiness activities for aficamten. Fady Malik, EVP of R&amp;D, will provide updates related to the clinical development program and medical affairs activities for aficamten. Stuart Kupfer, SVP and Chief Medical Officer, will provide updates on the clinical development program for omecamtiv mecarbil and ulacamten. Sung Lee, EVP and Chief Financial Officer, will<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4839026-cytokinetics-incorporated-cytk-q3-2025-earnings-call-transcript?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\" rel=\"nofollow\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Company Participants Diane Weiser &#8211; Senior Vice President of Corporate AffairsRobert I. Blum &#8211; CEO, President &amp; DirectorAndrew Callos &#8211; Executive VP&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1778,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":{"0":"post-15122","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros<\/title>\n<meta name=\"description\" content=\"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=15122\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros\" \/>\n<meta property=\"og:description\" content=\"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=15122\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T10:51:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=15122#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=15122\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript\",\"datePublished\":\"2025-11-06T10:51:30+00:00\",\"dateModified\":\"2025-11-06T10:51:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=15122\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=15122#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=15122\",\"url\":\"https:\/\/infundpros.com\/?p=15122\",\"name\":\"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2025-11-06T10:51:30+00:00\",\"dateModified\":\"2025-11-06T10:51:30+00:00\",\"description\":\"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=15122#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=15122\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=15122#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros","description":"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=15122","og_locale":"en_US","og_type":"article","og_title":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros","og_description":"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive","og_url":"https:\/\/infundpros.com\/?p=15122","og_site_name":"inFundPros","article_published_time":"2025-11-06T10:51:30+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","type":"image\/png"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=15122#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=15122"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript","datePublished":"2025-11-06T10:51:30+00:00","dateModified":"2025-11-06T10:51:30+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=15122"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=15122#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=15122","url":"https:\/\/infundpros.com\/?p=15122","name":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2025-11-06T10:51:30+00:00","dateModified":"2025-11-06T10:51:30+00:00","description":"Company Participants Diane Weiser - Senior Vice President of Corporate AffairsRobert I. Blum - CEO, President &amp; DirectorAndrew Callos - Executive","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=15122#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=15122"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=15122#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript"}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/15122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15122"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/15122\/revisions"}],"predecessor-version":[{"id":15123,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/15122\/revisions\/15123"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/1778"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}